GABPA and Parkinson disease: Activation of Nrf2 by drugs or genetic manipulations is demonstrated to alleviate PD induced by agents such as MPP+, rotenone, and H2O2, as well as genetic factors that can protect neurons in vitro and in vivo against DA-related neurotoxicity [20].